Advocacy

In this issue of AcademyHealth's Situation Report, we highlight how recent court rulings have preserved critical funding. We also examine mounting concerns over the erosion of evidence-based policymaking, debates over ACA affordability and rising premiums, and emerging fiscal pressures facing Medicaid and health insurers.

In this issue of AcademyHealth’s Situation Report, we spotlight policy changes that AcademyHealth will be watching in 2026 to keep the field informed including federal funding decisions, the impact of HR1 and Medicaid cuts, ACA subsidies and health care affordability and other developments related to the stability of the health services research ecosystem.

In this edition of AcademyHealth's Situation Report, we reflect on our ongoing efforts to keep readers informed and advocate for health services researchers and evidence-based policy through 2025 and beyond.

In this issue of AcademyHealth’s Situation Report, we examine the continued debate around Affordable Care Act (ACA) subsidies and the offering of tax-free funds, as well as concerns around costs and coverage. Experts also highlight risks of vaccine policy changes.

In this issue of AcademyHealth’s Situation Report, we highlight competing health care proposals--most of which don't extend ACA tax credits, a new CMS model that could accelerate digital chronic care, politically driven conditions tied to a $50 billion rural health fund, rising concerns over FDA vaccine oversight as well as calls to reexamine the childhood immunization schedule.

In this issue of AcademyHealth's Situation Report, we highlight a major CDC advisory panel vote to narrow a decades-old hepatitis B vaccination policy, new federal borrowing caps that may reshape the health research workforce, issues related to SNAP administrative funding, evolving FDA regulatory standards, and ongoing concerns about political influence in NIH grantmaking.

In this issue of AcademyHealth’s Situation Report, we highlight ongoing policy changes regarding Medicaid work requirements, the future of the children’s vaccine schedule, and fewer grants being awarded from the NIH and NSF leading to less research – especially research related to underserved patients.